These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 25051504)

  • 1. Comparative gene and protein expression analyses of a panel of cytokines in acute and chronic drug-induced liver injury in rats.
    Hanafusa H; Morikawa Y; Uehara T; Kaneto M; Ono A; Yamada H; Ohno Y; Urushidani T
    Toxicology; 2014 Oct; 324():43-54. PubMed ID: 25051504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A computational toxicogenomics approach identifies a list of highly hepatotoxic compounds from a large microarray database.
    Rueda-Zárate HA; Imaz-Rosshandler I; Cárdenas-Ovando RA; Castillo-Fernández JE; Noguez-Monroy J; Rangel-Escareño C
    PLoS One; 2017; 12(4):e0176284. PubMed ID: 28448553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
    Eun JW; Bae HJ; Shen Q; Park SJ; Kim HS; Shin WC; Yang HD; Jin CY; You JS; Kang HJ; Kim H; Ahn YM; Park WS; Lee JY; Nam SW
    J Appl Toxicol; 2015 Feb; 35(2):152-64. PubMed ID: 25231249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th2 cytokine-mediated methimazole-induced acute liver injury in mice.
    Kobayashi M; Higuchi S; Ide M; Nishikawa S; Fukami T; Nakajima M; Yokoi T
    J Appl Toxicol; 2012 Oct; 32(10):823-33. PubMed ID: 22407903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
    Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
    Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is toxicogenomics a more reliable and sensitive biomarker than conventional indicators from rats to predict drug-induced liver injury in humans?
    Zhang M; Chen M; Tong W
    Chem Res Toxicol; 2012 Jan; 25(1):122-9. PubMed ID: 22122743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel cell-based assay for the evaluation of immune- and inflammatory-related gene expression as biomarkers for the risk assessment of drug-induced liver injury.
    Oda S; Matsuo K; Nakajima A; Yokoi T
    Toxicol Lett; 2016 Jan; 241():60-70. PubMed ID: 26546780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatotoxicants induce cytokine imbalance in response to innate immune system.
    Goto S; Deguchi J; Nishio N; Nomura N; Funabashi H
    J Toxicol Sci; 2015 Jun; 40(3):389-404. PubMed ID: 25972199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel transcriptomics based in vitro method to compare and predict hepatotoxicity based on mode of action.
    De Abrew KN; Overmann GJ; Adams RL; Tiesman JP; Dunavent J; Shan YK; Carr GJ; Daston GP; Naciff JM
    Toxicology; 2015 Feb; 328():29-39. PubMed ID: 25475144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling in rat liver treated with various hepatotoxic-compounds inducing coagulopathy.
    Hirode M; Omura K; Kiyosawa N; Uehara T; Shimuzu T; Ono A; Miyagishima T; Nagao T; Ohno Y; Urushidani T
    J Toxicol Sci; 2009 Jun; 34(3):281-93. PubMed ID: 19483382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a cell-based assay system considering drug metabolism and immune- and inflammatory-related factors for the risk assessment of drug-induced liver injury.
    Yano A; Oda S; Fukami T; Nakajima M; Yokoi T
    Toxicol Lett; 2014 Jul; 228(1):13-24. PubMed ID: 24747151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicogenomic analysis of the gene expression changes in rat liver after a 28-day oral Tripterygium wilfordii multiglycoside exposure.
    Zhang Y; Jiang Z; Xue M; Zhang S; Wang Y; Zhang L
    J Ethnopharmacol; 2012 May; 141(1):170-7. PubMed ID: 22366672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hepatotoxicity: a predictive model based on focused illumina microarrays.
    Zidek N; Hellmann J; Kramer PJ; Hewitt PG
    Toxicol Sci; 2007 Sep; 99(1):289-302. PubMed ID: 17522070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress/reactive metabolite gene expression signature in rat liver detects idiosyncratic hepatotoxicants.
    Leone A; Nie A; Brandon Parker J; Sawant S; Piechta LA; Kelley MF; Mark Kao L; Jim Proctor S; Verheyen G; Johnson MD; Lord PG; McMillian MK
    Toxicol Appl Pharmacol; 2014 Mar; 275(3):189-97. PubMed ID: 24486436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
    Baeck C; Wehr A; Karlmark KR; Heymann F; Vucur M; Gassler N; Huss S; Klussmann S; Eulberg D; Luedde T; Trautwein C; Tacke F
    Gut; 2012 Mar; 61(3):416-26. PubMed ID: 21813474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the key innate genes related to individual variation in carbon tetrachloride-induced hepatotoxicity using a pre-biopsy procedure.
    Yun JW; Kim CW; Bae IH; Park YH; Chung JH; Lim KM; Kang KS
    Toxicol Appl Pharmacol; 2009 Aug; 239(1):55-63. PubMed ID: 19481104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome analyses demonstrate that Peroxisome Proliferator-Activated Receptor α (PPARα) activity of an ultraviolet absorber, 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)benzotriazole, as possible mechanism of their toxicity and the gender differences.
    Hirata-Koizumi M; Ise R; Kato H; Matsuyama T; Nishimaki-Mogami T; Takahashi M; Ono A; Ema M; Hirose A
    J Toxicol Sci; 2016; 41(5):693-700. PubMed ID: 27665778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and regulation of histidine decarboxylase mRNA expression in the uterus during pregnancy in the mouse.
    Wood GW; Hausmann EH; Choudhuri R; Dileepan KN
    Cytokine; 2000 Jun; 12(6):622-9. PubMed ID: 10843737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development.
    Blomme EA; Yang Y; Waring JF
    Toxicol Lett; 2009 Apr; 186(1):22-31. PubMed ID: 18996174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species-specific differences in coumarin-induced hepatotoxicity as an example toxicogenomics-based approach to assessing risk of toxicity to humans.
    Uehara T; Kiyosawa N; Shimizu T; Omura K; Hirode M; Imazawa T; Mizukawa Y; Ono A; Miyagishima T; Nagao T; Urushidani T
    Hum Exp Toxicol; 2008 Jan; 27(1):23-35. PubMed ID: 18480146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.